Vitrag Biofabs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 22 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 23.88 Cr
as on 11-12-2024
- Revenue 220.09%
(FY 2020)
- Profit 69.58%
(FY 2020)
- Ebitda 48.13%
(FY 2020)
- Net Worth 30.00%
(FY 2020)
- Total Assets 1635.85%
(FY 2020)
About Vitrag Biofabs
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹23.88 Cr.
Siddharth Talati, Sucheta Talati, Krishnojirao Rao, and One other member serve as directors at the Company.
- CIN/LLPIN
U33110MH2002PTC135903
- Company No.
135903
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 May 2002
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vitrag Biofabs?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siddharth Talati  | Director | 18-Sep-2017 | Current |
| Sucheta Talati | Director | 18-Sep-2017 | Current |
| Krishnojirao Rao | Director | 24-Dec-2019 | Current |
| Nagaraja Abhinandan | Director | 25-Jan-2020 | Current |
Financial Performance and Corporate Structure Insights of Vitrag Biofabs.
Vitrag Biofabs Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 220.09% increase. The company also saw a substantial improvement in profitability, with a 69.58% increase in profit. The company's net worth Soared by an impressive increase of 30%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vitrag Biofabs?
In 2020, Vitrag Biofabs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Adeshwar Meditex LimitedActive 17 years 8 monthsKrishnojirao Rao and Nagaraja Abhinandan are mutual person
- Moksha Biosurgicals Private LimitedActive 18 years 6 months
Siddharth Talati and Sucheta Talati are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 19 Jul 2017 | ₹23.88 Cr | Open |
How Many Employees Work at Vitrag Biofabs?
Unlock and access historical data on people associated with Vitrag Biofabs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vitrag Biofabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vitrag Biofabs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
